Sort by

Send to

Choose Destination

Search results

Items: 5


Visualisation of interstitial lung disease by molecular imaging of integrin αvβ3 and somatostatin receptor 2.

Schniering J, Benešová M, Brunner M, Haller S, Cohrs S, Frauenfelder T, Vrugt B, Feghali-Bostwick CA, Schibli R, Distler O, Mueller C, Maurer B.

Ann Rheum Dis. 2019 Feb;78(2):218-227. doi: 10.1136/annrheumdis-2018-214322. Epub 2018 Nov 17. Erratum in: Ann Rheum Dis. 2019 Jun;78(6):e60.


In Vivo Labeling of Plasma Proteins for Imaging of Enhanced Vascular Permeability in the Lungs.

Schniering J, Borgna F, Siwowska K, Benešová M, Cohrs S, Hasler R, van der Meulen NP, Maurer B, Schibli R, Müller C.

Mol Pharm. 2018 Nov 5;15(11):4995-5004. doi: 10.1021/acs.molpharmaceut.8b00606. Epub 2018 Sep 28.


Evaluation of 99mTc-rhAnnexin V-128 SPECT/CT as a diagnostic tool for early stages of interstitial lung disease associated with systemic sclerosis.

Schniering J, Guo L, Brunner M, Schibli R, Ye S, Distler O, Béhé M, Maurer B.

Arthritis Res Ther. 2018 Aug 16;20(1):183. doi: 10.1186/s13075-018-1681-1.


Tie2 as a novel key factor of microangiopathy in systemic sclerosis.

Moritz F, Schniering J, Distler JHW, Gay RE, Gay S, Distler O, Maurer B.

Arthritis Res Ther. 2017 May 25;19(1):105. doi: 10.1186/s13075-017-1304-2.


Systemic sclerosis: The need for structured care.

Morrisroe K, Frech T, Schniering J, Maurer B, Nikpour M.

Best Pract Res Clin Rheumatol. 2016 Feb;30(1):3-21. doi: 10.1016/j.berh.2016.04.004. Epub 2016 May 1. Review.


Supplemental Content

Loading ...
Support Center